Related Experiment Video
Updated: May 6, 2026
16:49
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
11.2K
Interferon-free regimens for hepatitis C: combine and conquer
Valérie Martel-Laferrière1, Kian Bichoupan, Douglas T Dieterich
1Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, 10129, USA, valerie.martel-laferriere@umontreal.ca.
Summary
New interferon-free direct-acting antiviral (DAA) regimens offer high sustained virologic response rates for hepatitis C virus (HCV) patients. These advanced treatments promise improved outcomes, especially for those unresponsive to or intolerant of older therapies.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Hepatitis C virus (HCV) treatment has been revolutionized by direct-acting antiviral agents (DAAs).
- Interferon-based therapies presented significant side effects and limited efficacy for some patients.
- The development of interferon-free regimens marks a significant advancement in HCV management.
Purpose of the Study:
- To review emerging interferon-free regimens for HCV currently in Phase II or III trials.
- To analyze sustained virologic response (SVR) data from these novel treatment strategies.
- To discuss the clinical successes and potential challenges associated with interferon-free HCV therapy.
Main Methods:
- Review of clinical trial data for interferon-free direct-acting antiviral regimens.
- Analysis of sustained virologic response rates in diverse patient populations.
- Evaluation of treatment outcomes in patients with specific HCV genotypes, cirrhosis, HIV coinfection, or post-transplant status.
Main Results:
- Many direct-acting antiviral combinations demonstrate sustained virologic response rates exceeding 90%.
- High efficacy is observed in patients previously treated unsuccessfully, including null responders and those who failed protease inhibitor regimens.
- Interferon-free regimens show particular benefit for HIV-infected and transplant patients due to a reduced side effect profile.
Conclusions:
- Interferon-free regimens represent a major therapeutic advance for hepatitis C virus infection.
- While highly effective, certain patient subgroups (e.g., genotypes 1a/3, cirrhosis) may require further optimization.
- These novel regimens offer a promising future for improving long-term outcomes in a broad range of HCV patients.
More Related Videos
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
01:25Hepatitis
99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
01:28Viral Hepatitis I: Introduction
28
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28
01:10Retrovirus Life Cycles
43.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.1K
02:33Retroviruses
12.3K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.3K
01:29Subviral Agents
940
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
940